Sign up Australia
Proactive Investors - Run By Investors For Investors

eSense-Lab reveals robust antioxidant activity for its medical cannabis terpenes

eSense recently signed a deal to develop a beer product line that is infused with terpenes.
a doctor prescribing medical cannabis
Terpenes are responsible for the aroma of cannabis

eSense-Lab Ltd (ASX:ESE) has achieved robust antioxidant activity for its medical cannabis terpene blends, manifested by a dose response of up to 5%.

Terpenes are organic compounds found in plants and are responsible for the aroma of cannabis.

eSense conducted tests for antioxidant activity across its medical cannabis terpene blends including Girl Scout Cookies, OG-Kush, Sour Diesel, Jack Herer, Daniel, Super Lemon Haze, Gorilla Glue, Chees and Granddaddy Purple.

A clear antioxidant activity could be seen for each one of the tested blends.

Girl Scout Cookies, OG-Kush, Sour Diesel, Jack Herer and Daniel presented the most potent antioxidant activity, while Super Lemon Haze, Gorilla Glue, Chees and Granddaddy Purple were slightly weaker but still significantly active.

Chees and Gorilla Glue were tested in alignment with similar competitor's formulations and were found to be significantly more potent in terms of antioxidant activity.

eSense to develop a terpene-infused line of beer

The company recently signed a memorandum of understanding with Netherlands-based alcoholic beverages manufacturer Progressive Brands BV to develop a beer product line that is infused with terpenes.

eSense estimates a terpene-infused product from Progressive Brands can reach the market within six months.

Progressive Brands has the ability to produce circa one million bottles of the new terpene infused product once it is developed and commercialised.

Once launched to consumers by Progressive Brands, eSense will receive royalties from the sales of the product.

View full ESE profile View Profile

esense-Lab Timeline

Newswire
January 11 2018

Related Articles

Canntab pills
June 02 2018
The company is putting a pharmaceutical spin on the growing cannabis market
1519327525_WeedMD-photo-for-Proactive.jpg
February 23 2018
The company is developing its medical cannabis for both domestic and global markets

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use